Article
6-Mercaptopurine pharmacokinetics after use of azathioprine in renal transplant recipients with intermediate or high thiopurine methyl transferase activity phenotype.
The Journal of pharmacy and pharmacology - 1 Nov 1998
Escousse A, Guedon F, Mounie J, Rifle G, Mousson C, D'Athis P
Abstract excerpt
Prevention of allograft transplant rejection by the immunosuppressive 6-thiopurine drug azathioprine is limited by haematological toxicity (leucopenia or agranulocytosis). This toxicity is particularly apparent in subjects with low thiopurine methyltransferase activity (TPMTase) phenotype (1% in the Caucasian population). The thiopurine derivative 6-mercaptopurine is the active metabolite of azathioprine, and it...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
